These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29067186)

  • 61. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
    Dehoux L; Hogan J; Dossier C; Fila M; Niel O; Maisin A; Macher MA; Kwon T; Baudouin V; Deschênes G
    Pediatr Nephrol; 2016 Nov; 31(11):2095-101. PubMed ID: 27263020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.
    Krejci M; Doubek M; Buchler T; Brychtova Y; Vorlicek J; Mayer J
    Ann Hematol; 2005 Oct; 84(10):681-5. PubMed ID: 16001244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
    Langone A; Shihab F; Pankewycz O; Doria C; Wiland A; McCague K; Chan L
    Clin Transplant; 2014 Sep; 28(9):961-7. PubMed ID: 24893821
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Clin Transplant; 1996 Feb; 10(1 Pt 2):131-5. PubMed ID: 8680050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
    Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.
    Swigris JJ; Olson AL; Fischer A; Lynch DA; Cosgrove GP; Frankel SK; Meehan RT; Brown KK
    Chest; 2006 Jul; 130(1):30-6. PubMed ID: 16840379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
    Han CH; Li HF; Wang YX; Zhang M; Wang Y; Yin M; Min ZL; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1327-32. PubMed ID: 16029632
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients.
    Sollinger H
    Transplant Proc; 2004 Mar; 36(2 Suppl):517S-520S. PubMed ID: 15041399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment With Cytarabine at Initiation of Therapy With Cyclosporine and Glucocorticoids for Dogs With Meningoencephalomyelitis of Unknown Origin Is Not Associated With Improved Outcomes.
    Barber R; Downey Koos L
    Front Vet Sci; 2022; 9():925774. PubMed ID: 35754543
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic Factors for Recovery of Vision in Canine Optic Neuritis of Unknown Etiology: 26 Dogs (2003-2018).
    Posporis C; Beltran E; Dunning M; Espadas I; Gillespie S; Barry AT; Wessmann A
    Front Vet Sci; 2019; 6():415. PubMed ID: 31824972
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunosignature Differentiation of Non-Infectious Meningoencephalomyelitis and Intracranial Neoplasia in Dogs.
    Lake BB; Rossmeisl JH; Cecere J; Stafford P; Zimmerman KL
    Front Vet Sci; 2018; 5():97. PubMed ID: 29868618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.